Champix is a branded treatment containing the active ingredient varenicline, which helps people stop smoking. It aims to reduce nicotine cravings and withdrawal symptoms when quitting smoking.
Some people use Varenicline alongside counselling sessions and specialist advice. It’s from a category of medications called smoking cessation aids that aim to block the positive effects of nicotine on the brain.
Champix is a tablet treatment available on prescription. It was first developed by Pfizer in 1997. Trials for Pfizer’s Varenicline were carried out in 2006 and later approved. It was first licensed in Australia in January 2008..